| Literature DB >> 25795664 |
Arancha Sánchez1, Assen Roguev2, Nevan J Krogan2, Paul Russell3.
Abstract
Brc1, which was first identified as a high-copy, allele-specific suppressor of a mutation impairing the Smc5-Smc6 holocomplex in Schizosaccharomyces pombe, protects genome integrity during normal DNA replication and when cells are exposed to toxic compounds that stall or collapse replication forks. The C-terminal tandem BRCT (BRCA1 C-terminus) domain of fission yeast Brc1 docks with phosphorylated histone H2A (γH2A)-marked chromatin formed by ATR/Rad3 checkpoint kinase at arrested and damaged replication forks; however, how Brc1 functions in relation to other genome protection modules remains unclear. Here, an epistatic mini-array profile reveals critical requirements for Brc1 in mutants that are defective in multiple DNA damage response pathways, including checkpoint signaling by Rad3-Rad26/ATR-ATRIP kinase, DNA repair by Smc5-Smc6 holocomplex, replication fork stabilization by Mrc1/claspin and Swi1-Swi3/Timeless-Tipin, and control of ubiquitin-regulated proteolysis by the COP9 signalosome (CSN). Exogenous genotoxins enhance these negative genetic interactions. Rad52 and RPA foci are increased in CSN-defective cells, and loss of γH2A increases genotoxin sensitivity, indicating a critical role for the γH2A-Brc1 module in stabilizing replication forks in CSN-defective cells. A negative genetic interaction with the Nse6 subunit of Smc5-Smc6 holocomplex indicates that the DNA repair functions of Brc1 and Smc5-Smc6 holocomplex are at least partially independent. Rtt107, the Brc1 homolog in Saccharomyces cerevisiae, has a very different pattern of genetic interactions, indicating evolutionary divergence of functions and DNA damage responses.Entities:
Keywords: Brc1; CSN/signalosome complex; DNA damage response; Schizosaccharomyces pombe
Mesh:
Substances:
Year: 2015 PMID: 25795664 PMCID: PMC4426379 DOI: 10.1534/g3.115.017251
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Summary of significant enriched GO categories for biological function of genes with genetic interactions positively correlated with brc1 (P ≤ 0.01)
| Process | Brc1 E-MAP Functional Groups |
|---|---|
| Cellular response to DNA damage stimulus | srs2, csn1, rad1, dbl1, rad2, ssb3, rad9, rad17, pku80, hus1, hat1, ddb1, mms22, rad26, hrq1, nse6, arp42, apn2, pnk1, swi3 |
| DNA repair | srs2, ddb1, mms22, rad1, rad2, ssb3, rad9, rad17, pku80, hus1, hrq1, arp42, pnk1, apn2, hat1 |
| DNA damage checkpoint | hus1, rad26, rad1, dbl1, rad9, rad17 |
| Chromatin modification | ubp8, ngg1, spt3, pmt3, nrl1, clr1, raf1, arp42, set1, snt1, hat1 |
| Cullin deneddylation | csn1, csn5, csn71 |
| Others | cbf11, dcd1, vps60, SPBC1711.15C, SPBC1289.14, mpp6, SPAC1635.01, SPAC1071.09C, SPBP16F5.05C, naa30, nup60, SPBP16F5.08C, rga8, SPBC651.02, urm1,SPCC1442.02, ppk3, sde2, SPBC27.05, pmp3, SPBC1711.09C, hmt1, atg22, fep1 |
GO, Gene Ontology; E-MAP, epistatic miniarray profile.
Summary of significant enriched GO categories for biological function of genes with genetic interactions positively correlated with RTT107 (P ≤ 0.01)
| Process | RTT107 E-MAP Functional Groups |
|---|---|
| DNA metabolic process | RRM3, MND2, SGS1, RMI1, POL30, SPT4, TSA1, MRE11, SWI6, XRS2, RTT101, SLX5, TEL1, TOP3, SRS2, MSH1, NEJ1, NUP84 |
| DNA repair | RRM3, MRE11, XRS2, SGS1, SLX5, TEL1, SRS2, MSH1, NEJ1, POL30, NUP84, SPT4 |
| Double-strand break repair | SRS2, TEL1, NEJ1, NUP84, MRE11, XRS2, SGS1 |
| Double-strand break repair via nonhomologous end joining | SRS2, NEJ1, MRE11, XRS2 |
| Response to stress | RRM3, YOR338W, SGS1, RMI1, POL30, SPT4, TSA1, SWI6, XRS2, MRE11, RTT101, SLX5, TEL1, SRS2, MSH1, NEJ1, NUP84 |
| Telomere maintenance and organization | TOP3, TEL1, RRM3, XRS2, SGS1, SLX5 |
| Cell cycle | CLB2, TSA1, MND2, MRE11, XRS2, SWI6, YOR338W, SGS1, RTT101, RMI1, TEL1, TOP3, CDC10, POL30 |
| Chromosome organization | RRM3, MND2, XRS2, SGS1, SLX5, RMI1, TEL1, TOP3, POL30, NUP84, SPT4 |
| DNA recombination | SRS2, TOP3, MND2, MRE11, SWI6, SGS1 |
| Others | RPN6, RPA190, YNR048W, GET2, AIM4, REB1, NUT1, BEM2, RPN10, TAH1, SRP40, DST1 |
GO, Gene Ontology; E-MAP, epistatic miniarray profile.
Summary of genetic interactions involving brc1Δ
| Allele | Function | Untreated | UV | HU | CPT | MMS |
|---|---|---|---|---|---|---|
| Signalosome complex subunit | YES | YES | YES | YES | YES | |
| Damage DNA binding protein Part of the ubiquitin ligase complex | YES | YES | YES | YES | YES | |
| Signalosome complex subunit | Yes | Yes | Yes | Yes | Yes | |
| Cell cycle arrest | Yes | YES | YES | YES | YES | |
| RFC related checkpoint protein | Yes | − | YES | YES | YES | |
| ATP-dependent DNA helicase | Yes | YES | YES | YES | YES | |
| Ku protein (NHEJ) | No | YES | YES | YES | YES | |
| DNA kinase/phosphatase (SSBR) | YES | YES | YES | YES | YES | |
| Replication fork protection complex subunit | Yes | Yes | Yes | Yes | Yes | |
| Silencing defective protein | Yes | YES | YES | YES | YES | |
| Rik1-associated factor | No | Yes | Yes | Yes | Yes | |
| Histone lysine methyltransferase | No | No | R | No | No | |
| Set3 complex subunit | No | No | Yes | Yes | Yes | |
| Chromosome segregation impaired protein 1 | No | R | R | R | R | |
| MutS protein homolog 2 | No | No | No | Yes | Yes | |
| CENP-B homolog | No | No | No | Yes | Yes |
Double mutants were assessed for growth in the absence or presence of specified genotoxins. UV, ultraviolet; HU, hydroxyurea; CPT, camptothecin; MMS, methyl methanesulfonate; YES, strong negative interaction; Yes, negative interaction; No, no genetic interaction; R, suppression.
Figure 1Critical requirement of COP9/Signalosome (CSN) in brc1Δ cells. Genetic interaction between Brc1 and Csn1 (A) or Csn5 (B). 10-fold serial dilutions of the indicated strains were exposed to the indicating DNA-damaging agents. Plates were incubated at 30° for 3−4 d. CPT, camptothecin; HU, hydroxyurea; MMS, methyl methanesulfonate; WT, wild type.
Figure 2Genetic interactions among Brc1, Ddb1, and Spd1. 10-fold serial dilutions of the indicated strains were exposed to the indicating DNA damaging agents. Plates were incubated at 30° for 3−4 d. CPT, camptothecin; HU, hydroxyurea; MMS, methyl methanesulfonate; WT, wild type.
Figure 3Increased Rad52 and RPA foci in csn1Δ cells. Cells expressing Rad52-yellow fluorescentprotein (A) or RPA(Ssb1)-green fluorescent protein (B) were cultured in minimal medium at 25° until mid-log phase. Foci were scored in three independent experiments. Rad52 foci in brc1Δcsn1Δ cells are statistically increased relative to csn1∆ cells (two-tailed Student’s t-test, P-value 0.0015). Error bars correspond to standard deviations of the means. Asterisk depicts statistically significant differences between the bracketed strains as determined by a two-tailed Student’s t-test, P-value ≤ 0.05.
Figure 4Genetic interactions among Brc1, Csn1, and Spd1. 10-fold serial dilutions of the indicated strains were exposed to the indicating DNA damaging agents. Plates were incubated at 30° for 3−4 d. CPT, camptothecin; HU, hydroxyurea; MMS, methyl methanesulfonate; WT, wild type.
Figure 5Critical requirement of γH2A in csn1Δ cells. Genetic interaction between Csn1 and htaAQ (A) or Crb2 (B). 10-fold serial dilutions of the indicated strains were exposed to the indicating DNA-damaging agents. Plates were incubated at 30° for 3−4 d. CPT, camptothecin; HU, hydroxyurea; MMS, methyl methanesulfonate; WT, wild type.